Abstract

Background: Acinetobacter is a serious nosocomial pathogen causing critical morbidity and mortality. The drug resistance of this organism is alarmingly high leaving few options for treatment. Numerous mechanisms are involved in its resistance to drug therapy. The active efflux mechanisms are an important factor for the development of multidrug-resistant Acinetobacter which is regulated by the AdeRS operon. The aim of this study end to determine the expression of AdeR and AdeS genes in multidrug‑resistant strains of Acinetobacter isolated from patients in Menoufia University Hospitals. Methods: This study included 100 strains of drug-resistant Acinetobacter spp., isolated from patients in Menoufia University Hospitals. They were collected from different clinical samples. Acinetobacter spp., strains were identified and their antibiotic susceptibilities were determined. Real-time PCR was performed to detect the expression of AdeR and AdeS genes. Results: The resistance of Acinetobacter spp., isolates to tested antibiotics were (94%) to piperacillin-tazobactam, (90%) to ampicillin-sulbactam, (80%) to ceftazidime, (55%) to levofloxacin, (50%) to amikacin, and (~52%) to carbapenems. The AdeR and AdeS genes were expressed in (84%) and (88%) of isolates, respectively. The AdeR and AdeS genes were expressed in (88.4%) and (90.7%) of multidrug-resistant strains, respectively. Conclusion: The majority of Acinetobacter spp., isolates are highly resistant to the most commonly used antibiotics. Also, high expression of adeRS genes may be responsible for the observed resistance among Acinetobacter isolates that demonstrate the possible role of efflux pump regulator genes in multidrug-resistant Acinetobacter.

Highlights

  • Acinetobacter is an aerobic, non-motile, nonfermenting, oxidase negative, catalase-positive, Gram-negative, opportunistic pathogen that plays an important role in nosocomial infections of immunocompromised patients [1]

  • This study was carried out by using 100 nonrepetitive drug-resistant Acinetobacter isolates collected from different clinical specimens including sputum, endotracheal aspirate, bronchoalveolar aspirate, urine, blood, and wound swabs from patients in Menoufia University Hospitals

  • Bacterial isolates As shown in table (2), 85% of patients with acinetobacter infections had associated co-morbidity, and 87% of patients infected with Acinetobacter spp., were exposed to an invasive procedure and exposed to previous antibiotic therapy

Read more

Summary

Introduction

Acinetobacter is an aerobic, non-motile, nonfermenting, oxidase negative, catalase-positive, Gram-negative, opportunistic pathogen that plays an important role in nosocomial infections of immunocompromised patients [1] This opportunistic bacterium is resistant to several types of antibiotics and responsible for many infections, including surgical wound infection, meningitis, ventilator-associated pneumonia, urinary tract infection, and bacteriemia [2]. Objective: The aim of this study was to determine the expression of AdeR and AdeS genes in multidrug-resistant strains of Acinetobacter isolated from patients in Menoufia University Hospitals. Methods: This study included 100 strains of drug-resistant Acinetobacter isolated from patients in Menoufia University Hospitals. They were collected from different clinical samples.

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.